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SIRT3 as a Regulator of Hepatic Autophagy 
Autophagy is one of the major degradative pathways for excessive nutrient deposits 
including lipid droplets and glycogen granules.(1) It was recently shown to play a crucial role 
in mediating essential homeostatic functions in the liver. Autophagy is also critical for 
maintaining quality and quantity of organelles such as mitochondria and peroxisomes, and 
for eliminating toxic protein aggregates accumulating during alcoholic and non-alcoholic 
steatohepatitis. It is important to understand how hepatic autophagy is physiologically 
regulated, and how the homeostatic function of autophagy is impaired during liver 
pathologies. 
Sirtuins are a family of seven NAD+-dependent protein deacetylases/deacylases. The 
mitochondrial sirtuin SIRT3 is responsible for bulk mitochondrial protein deacetylation.(2) 
Livers from Sirt3 KO mice exhibit hyperacetylation of mitochondrial proteins, associated with 
deleterious metabolic phenotypes: altered starvation response, insulin resistance, and fat 
accumulation. SIRT3 exerts multiple effects in mitochondria, promoting ATP generation, 
beta-oxidation, and urea cycle activity, while suppressing reactive oxygen species (ROS) 
levels and cell death, among many others. A large literature has revealed protective effects 
of SIRT3 in diverse tissues, including liver. These effects of SIRT3 may reflect direct 
deacetylation and activation of mitochondrial protein targets by SIRT3, and/or roles for 
SIRT3 in activating upstream regulators of mitochondrial function, like AMPK and 
PGC1alpha. 
Among the sirtuins, SIRT1 has been shown to promote autophagy in multiple contexts.(3) 
SIRT1 activates core autophagy proteins through direct deacetylation, and indirectly 
promotes autophagy via deacetylation and activation of FoxO-family transcription factors. A 
growing literature links other sirtuins, such as SIRT2,(3) to the regulation of autophagy, 
though mechanisms that remain to be clearly elucidated.  
In this issue of HEPATOLOGY, Li et al.(4) show that SIRT3 is an important regulator of 
hepatic autophagy (Fig. 1). They find, somewhat surprisingly, that SIRT3 upregulation 
actually attenuates autophagic flux, while SIRT3 inhibition elevates it. SIRT3-mediated 
autophagy inhibition sensitized HepG2 cells to palmitic acid (PA)-induced cell death, while 
SIRT3 silencing, which upregulates autophagy, protected against it. These results suggested 
that SIRT3 antagonizes autophagy, and therefore potentially plays a pathogenetic role in 
lipotoxic injury and fatty liver pathology. 
The autophagy-controlling role of SIRT3 was also examined in mouse models of non-
alcoholic fatty liver disease. Livers from global Sirt3 KO mice exhibited robust autophagic 
upregulation, while AAV-mediated hepatic SIRT3 overexpression inhibited autophagy, and 
exacerbated palm oil-induced liver damage. Although these results suggest a role for SIRT3 
in promoting fatty liver disease, a liver-specific Sirt3 KO strain was not analyzed, leaving a 
possibility that SIRT3’s effects on hepatic autophagy are indirect. 
Although SIRT3 is almost exclusively mitochondrial, most autophagic components are 
cytosolic; therefore, communication between mitochondria and cytosol must exist to allow 
SIRT3 to inhibit autophagy. Li et al. focused on AMPK, a kinase responsive to mitochondrial 
energetics and capable of regulating autophagic flux. They found that SIRT3 overexpression 
inhibited AMPK and activated mTORC1, while SIRT3 inhibition produced the opposite 
effects. AMPK inhibition prevented the ability of SIRT3 ablation to activate autophagy and 
protect cells from PA-induced lipotoxicity. These data support a role for SIRT3 in AMPK 
inhibition. However, SIRT3 has been also reported to activate AMPK.(2) In addition, SIRT3 
controlled expression of both LC3-I and LC3-II, while AMPK is known to upregulate the LC3 
lipidation process, which converts LC3-I to LC3-II. Therefore, mechanisms of how SIRT3 
regulates AMPK and whether this indeed mediates SIRT3’s autophagy-controlling role need 
to be further clarified. 
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Li et al. then examined the mechanism of SIRT3 control of AMPK. SIRT3 is known to 
deacetylate and activate the mitochondrial antioxidant enzyme MnSOD. In SIRT3-silenced 
cells, MnSOD overexpression or antioxidant treatment inhibited AMPK and autophagy, 
whereas the superoxide inducer rotenone activated them. These results suggest that 
MnSOD activation and subsequent superoxide suppression are key events through which 
SIRT3 suppresses AMPK. It remains possible that SIRT3-regulated mitochondrial energy 
production contributes to AMPK regulation. In addition, how superoxide regulates AMPK is 
currently elusive. 
Finally, the impact of lipotoxic insult on SIRT3 level and activity was evaluated. PA (in 
HepG2 cells) or palm oil diet (in mouse liver) induced SIRT3 expression and mitochondrial 
protein deacetylation. In contrast, oleic acid or corn oil diet did not produce these effects, 
suggesting that saturated fatty acids specifically drive SIRT3 upregulation. Li et al. proposed 
that saturated fatty acids upregulate SIRT3, which in turn inhibits autophagy and 
exacerbates fatty liver pathologies. 
In light of prior findings, this work opens many questions. First, using global Sirt3 KO mice, 
SIRT3 was originally characterized as a suppressor of fatty liver pathologies.(5) However, 
another study using liver-specific Sirt3 KO mice failed to show a role for hepatic SIRT3 in fat 
or redox metabolism.(6) These previous reports contradict one another, as well as the 
findings of Li et al. Differences in the high fat diet (HFD) formulation could be the source of 
these disparate outcomes. The palm oil diet that Li et al. used is more lipotoxic than 
conventional HFD, and can induce spontaneous liver damage. Hirschey et al. reported that, 
although short-term HFD feeding transiently upregulates SIRT3 expression, longer-term 
HFD downregulates SIRT3.(5) HFD can also impair SIRT3 activity without altering its 
expression.(7) How SIRT3 is regulated during lipotoxicity needs to be mechanistically 
investigated. Likewise, in contrast to the results of Li et al., multiple groups have shown that 
SIRT3 promotes autophagy and mitophagy in cardiomyocytes and other cell lines.(8-10) It can 
be speculated that, while mitochondrial SIRT3 proximally upregulates mitophagy specifically, 
it remotely produces inhibitory effects on general macroautophagy. It is also possible that the 
role of SIRT3 may vary depending on the physiological context, as it controls a diverse set of 
mitochondrial proteins that have different functions. Still, how SIRT3 can produce opposing 
effects on autophagy and fatty liver pathologies in different studies will require further study 
for resolution. 
Importantly, lipotoxicity and obesity exert SIRT3-independent impacts on mitochondrial 
metabolism and autophagy. As the effects of palm oil on AMPK and mTORC1 exceed that of 
SIRT3 overexpression, SIRT3 cannot be the sole molecular conduit of how lipotoxicity or 
obesity controls hepatic AMPK-mTORC1 signaling. In addition, saturated fatty acids and 
obesity can inhibit hepatic autophagy through multiple mechanisms, including attenuation of 
autophagosomal-lysosomal fusion.(1) The role of SIRT3 in this process should be also 
investigated. 
In conclusion, Li et al. assign SIRT3 a novel function in regulating hepatic autophagy. Future 
studies should focus on elucidating the intricate relationships between SIRT3, autophagy 
and mitochondrial metabolism to better understand the molecular changes associated with 
SIRT3 during obesity and fatty liver disease. 
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FIGURE LEGENDS 
Fig. 1. SIRT3’s role in regulating hepatic autophagy. According to the current work by Li et 
al.,(4) mitochondrial SIRT3 inhibits hepatic autophagy through MnSOD-dependent modulation  
of AMPK-mTORC1 signaling (black arrows), in the context of fatty liver injury. In separate 
physiological contexts, SIRT3 also exhibits some autophagy-enhancing activities through 
different mechanisms (green arrows).(2, 8-10) Some graphics in this figure were obtained and 
modified from Servier Medical Art (http://www.servier.com/Powerpoint-image-bank). 
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Fig. 1. SIRT3’s role in regulating hepatic autophagy. According to the current work by Li et al.,(4) 
mitochondrial SIRT3 inhibits hepatic autophagy through MnSOD-dependent modulation  of AMPK-mTORC1 
signaling (black arrows), in the context of fatty liver injury. In separate physiological contexts, SIRT3 also 
exhibits some autophagy-enhancing activities through different mechanisms (green arrows).(2, 8-10) Some 
graphics in this figure were obtained and modified from Servier Medical Art 
(http://www.servier.com/Powerpoint-image-bank).  
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